Skip to main content
. 2019 May 23;104(6):1013–1024. doi: 10.1016/j.ajhg.2019.03.025

Table 2.

G × Cell-Proportion Interactions Identify Cell-Type-Specific eQTLs from Bulk Adipose-Tissue Gene-Expression Profiles

Cell Type SNP Gene β p Value Fairfax et al. Stimulus & Proxy SNP GTEx Top eQTL Tissues Regulatory Regions
macrophage rs61913538 CLEC12A 0.37 8.4 × 10−25 naive, rs7313235 WB, adipose, muscle blood promoter
macrophage rs1063355 HLA-DQA1 0.29 3.0 × 10−18 NA WB, skin, muscle blood promoter. breast/skin DNAase
macrophage rs1351111 KLRC4-KLRK1 −0.34 4.6 × 10−15 NA NA blood + skin promoter
macrophage rs1351111 KLRK1 −0.35 1.5 × 10−14 NA adipose, fibroblast, muscle blood + skin promoter
macrophage rs2422631 SIRPB1 −0.40 2.2 × 10−13 NA WB, lung, nerve blood DNAase
macrophage rs28383372 HLA-DQA2 0.25 2.2 × 10−13 NA WB, lung, adipose 5+-tissue promotor
macrophage rs866865 KCNMA1 −0.30 3.7 × 10−13 IFN-g, rs752372 WB, adipose, lung blood enhancer
macrophage rs2278589 MARCO −0.40 1.8 × 10−12 NA adipose, WB, skin adipocytes, monocytes
macrophage rs1063347 HLA-DQB1 −0.29 7.9 × 10−12 NA WB, lung, skin blood promoter + histone marks
macrophage rs634512 LYZ −0.27 2.2 × 10−11 LPS24, rs1384 WB, lung, artery blood promoter. breast/skin DNAase
macrophage rs4528348 MS4A14 0.26 5.4 × 10−11 LPS24, rs2233253 adipose, lung, nerve blood promoter + enhancer liver/lung enhancer + DNAase
macrophage rs2327276 VNN2 −0.34 7.8 × 10−11 IFN-g, rs1883613 adipose, WB, lung blood + skin promoter
endothelial rs28383362 HLA-DQA2 −0.34 1.5 × 10−22 NA WB, muscle, adipose blood promoter + enhancer
endothelial rs1884841 TC2N −0.23 1.0 × 10−12 NA nerve, adipose, artery blood DNAse + enhancer
endothelial rs182366 B3GALNT2 0.26 7.0 × 10−12 NA nerve, adipose, thyroid blood promoter, skin DNAase
endothelial rs2744944 UHRF1BP1 −0.26 8.16 × 10−12 NA artery, muscle, fibroblast blood enhancer
endothelial rs2977786 DEFB1 −0.27 4.3 × 10−11 NA adipose, heart, nerve 5-+ tissue promotor
endothelial rs61799378 SLC25A24 −0.28 1.5 × 10−10 NA testis, WB, fibroblast blood promoter
endothelial rs4728142 IRF5 −0.28 3.2 × 10−10 NA WB, artery, thyroid blood/fat promoter
endothelial rs9270111 HLA-DRB5 0.30 6.3 × 10−10 NA muscle, WB, adipose blood cell enhancer
endothelial rs3819715 HLA-DQB1 −0.35 9.0 × 10−10 NA adipose, muscle, skin blood cell enhancer
endothelial rs3760516 VAMP2 −0.33 9.6 × 10−10 NA nerve, brain, thyroid blood promoter + enhancer
adipocyte rs28383362 HLA-DQA2 0.26 4.2 × 10−13 NA WB, muscle, adipose blood promoter
adipocyte rs2977786 DEFB1 0.27 4.6 × 10−11 NA adipose, heart, nerve blood promoter
adipocyte rs1812350 B3GALNT2 −0.25 6.1 × 10−11 NA nerve, adipose, thyroid blood promoter
adipocyte rs1884841 TC2N 0.20 6.2 × 10−10 NA nerve, adipose, artery heart/muscle promoter

The first column, “Cell Type,” lists the cell-type proportion estimate included in the G × cell-proportion interaction model. Macrophage proportion interactions replicated in Fairfax et al., 201540 have proxy SNPs and stimuli condition annotated. The top three eQTL tissues in GTEx are listed on the basis of effect size. The “Regulatory Regions” column lists HaploRegv4 annotations at the lead SNP. All promoters, enhancers, and other regulatory annotation enrichments are derived from HaploRegv4.